Effect of reduced calcium on lysophosphatidylcholine-induced cardiac arrhythmias
- PMID: 4023041
- DOI: 10.1159/000138092
Effect of reduced calcium on lysophosphatidylcholine-induced cardiac arrhythmias
Abstract
Lysophosphatidylcholine (LPC) had recently been shown to accumulate in the ischemic heart and was demonstrated to be arrhythmogenic in perfused hearts. The present study was designed to examine the effects of calcium and verapamil on LPC-induced arrhythmias. Rat hearts were perfused through the aorta with oxygenated Krebs-Henseleit buffer at 37 degrees C. The occurrence of ventricular fibrillation was dependent on the LPC concentration and perfusion time. In subsequent experiments, each heart was perfused with a buffer containing 20 microM LPC for 3 min and was followed with a 10 min washout period. Ventricular fibrillation occurred in all 8 control experiments. When the Ca2+ concentration was reduced to half, only 3 out of 8 hearts fibrillated. In the presence of 0.2 mg/1 of verapamil, 7 out of 9 hearts fibrillated, and the time to fibrillation was not increased significantly by verapamil. These results suggest that calcium may be important in LPC-induced arrhythmias, and this effect is not significantly attenuated by the Ca2+ antagonist, verapamil.
Similar articles
-
Lysophosphatidylcholine-induced arrhythmias and its accumulation in the rat perfused heart.Br J Pharmacol. 1988 Feb;93(2):412-6. doi: 10.1111/j.1476-5381.1988.tb11448.x. Br J Pharmacol. 1988. PMID: 3359113 Free PMC article.
-
Effects of verapamil on electrophysiological disturbances induced by lysophosphatidylcholine in isolated rabbit hearts.Arch Int Pharmacodyn Ther. 1984 Jul;270(1):88-96. Arch Int Pharmacodyn Ther. 1984. PMID: 6497505
-
Protective effects of free polyunsaturated fatty acids on arrhythmias induced by lysophosphatidylcholine or palmitoylcarnitine in neonatal rat cardiac myocytes.Eur J Pharmacol. 1996 Feb 15;297(1-2):97-106. doi: 10.1016/0014-2999(95)00701-6. Eur J Pharmacol. 1996. PMID: 8851173
-
Lysophosphatidylcholine metabolism and cardiac arrhythmias.Can J Physiol Pharmacol. 1988 Mar;66(3):185-9. doi: 10.1139/y88-032. Can J Physiol Pharmacol. 1988. PMID: 3383014
-
A new approach to the development of anti-ischemic drugs: protective drugs against cell injury induced by lysophosphatidylcholine.Life Sci. 1998;62(17-18):1695-9. doi: 10.1016/s0024-3205(98)00130-1. Life Sci. 1998. PMID: 9585159 Review.
Cited by
-
The association of lysophosphatidylcholine with isolated cardiac myocytes.Lipids. 1990 Aug;25(8):450-4. doi: 10.1007/BF02538087. Lipids. 1990. PMID: 2215087
-
Hypocalcemia Induced Bronchospasm.Cureus. 2022 Jun 26;14(6):e26339. doi: 10.7759/cureus.26339. eCollection 2022 Jun. Cureus. 2022. PMID: 35903573 Free PMC article.
-
Mechanisms of the coronary vascular effects of platelet-activating factor in the rat perfused heart.Br J Pharmacol. 1991 May;103(1):1097-102. doi: 10.1111/j.1476-5381.1991.tb12306.x. Br J Pharmacol. 1991. PMID: 1652337 Free PMC article.
-
Coenzyme-A-Independent Transacylation System; Possible Involvement of Phospholipase A2 in Transacylation.Biology (Basel). 2017 Mar 30;6(2):23. doi: 10.3390/biology6020023. Biology (Basel). 2017. PMID: 28358327 Free PMC article. Review.
-
Lysophosphatidylcholine accumulation in the ischemic canine heart.Lipids. 1988 Jan;23(1):32-5. doi: 10.1007/BF02535301. Lipids. 1988. PMID: 3352470
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous